A sting in the tale - - Chromatography Online
A sting in the tale

The Column
Volume 8, Issue 21

Two novel peptides have been identified within the crude extract of Asian scorpion Buthus martensi Karsch venom using two-dimensional high perfomance liquid chromatography (2D-HPLC) and tandem mass spectrometry (MS–MS). Historically used in Chinese medicine to treat heart disease, the venom has potential applications in the development and identification of new drugs. Earlier this year, a study was published showing that peptides isolated from scorpion venom had anti-bacterial properties, specifically effective against established antibiotic‑resistant bacteria.1

Scorpion venom is a complex mixture of proteins, including a range of neurotoxic peptides that selectively block cell-to-cell signalling by selectively binding to ion-channels. These peptides can be used in pharmocological studies to block specific channels and signalling, potentially revealing new drug targets.

Based on genetic data, within the Buthus martensi Karsch venom it is estimated that there are 86 toxins, but only the presence of 46 peptides have been confirmed.2 The previous methods have been regarded as too low a sensitivity to detect all the petides present.

A group of investigators in China2 has identified two novel peptides, previously predicted to be present in scorpion venom-based on genetic data, but otherwise not found. Offline orthogonal two‑dimensional reversed-phase liquid chromatography/hydrophilic interaction liquid chromatography (2D-RPLC/HILIC) purification and collision-induced dissociation tandem mass spectrometry (CID-MS–MS) technique was used. Using bioinformatics the two novel peptides were predicted to be selective inhibitors of the potassium channel toxin α-KTx17 subfamily.

This research therefore has the potential to advance drug development through the discovery of new drug targets.

1. L. Cao et al., PLoS ONE, DOI:10.1371/journal.pone.0040135 (2012).

2. J. Xu et al., Proteomics, 12, 3076–3084 (2012).

This story originally appeared in The Column. Click here to view that issue.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters
Global E-newsletters subscribe here:




 

LCGC COLUMNISTS 2014

Sample Prep Perspectives | Ronald E. Majors:

LCGC Columnist Ron Majors, established authority on new column technologies, keeps readers up-to-date with new sample preparation trends in all branches of chromatography and reviews developments in existing technology lines.

LATEST: The Role of Selectivity in Extractions: A Case Study

History of Chromatography | Industry Veterans:

With each installment of this column, a different industry veteran covers an aspect of the evolution and continued development of the science of chromatography, from its birth to its eventual growth into the high-powered industry we see today.

LATEST: Georges Guiochon: Separation Science Innovator

MS — The Practical Art| Kate Yu:
Kate Yu is the editor of 'MS-The Practical Art' bringing her expertise in the field of mass spectrometry and hyphenated techniques to the pages of LCGC. In this column she examines the mass spectrometric side of coupled liquid and gas-phase systems. Troubleshooting-style articles provide readers with invaluable advice for getting the most from their mass spectrometers.

LATEST: Mass Spectrometry for Natural Products Research: Challenges, Pitfalls, and Opportunities


LC Troubleshooting | John Dolan:

LC Troubleshooting sets about making HPLC methods easier to master. By covering the basics of liquid chromatography separations and instrumentation, John Dolan, Vice President of LC Resources and world renowned expert on HPLC, is able to highlight common problems and provide remedies for them.

LATEST: LC Method Scaling, Part I: Isocratic Separations

More LCGC Chromatography-Related Columnists>>

LCGC North America Editorial Advisory Board>>

LCGC Europe Editorial Advisory Board>>

LCGC Editorial Team Contacts>>


Source: The Column,
Click here